Geoffrey M. Parker - May 16, 2024 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/Earl Douglas, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
May 16, 2024
Transactions value $
$1,000,001
Form type
4
Date filed
5/20/2024, 06:02 PM
Previous filing
May 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $1M +345K +42.07% $2.90 1.16M May 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering.